NCT07049497View on ClinicalTrials.gov

Study of Immune Response in Subjects Vaccinated Against SARS-CoV-2 Infection

CompletedOBSERVATIONAL
Enrollment

127

Participants

Timeline

Start Date

June 28, 2022

Primary Completion Date

July 20, 2022

Study Completion Date

May 15, 2024

Conditions
SAR-CoV-2Cellular Immune ResponseAntibody Response
Interventions
OTHER

Evaluation of the T cell response in terms of IFN-γ measured by ELISpot

The evaluation of the T cell response will be performed by quantifying the frequencies of SARS-CoV-2-specific T cells producing IFN-γ using an enzyme-linked immunospot assay (ELISpot), with cryopreserved PBMC collected at the designated timepoints (T0, T1, T2, T3, and T4)

Trial Locations (1)

20132

IRCCS Ospedale San Raffaele, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER